Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
12,919,477
-
Shares change
-
-160,831
-
Total reported value, excl. options
-
$3,057,974,702
-
Value change
-
-$38,046,344
-
Put/Call ratio
-
168%
-
Number of buys
-
117
-
Number of sells
-
-67
-
Price
-
$236.69
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2014
225 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q3 2014.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,919,477 shares
.
Largest 10 shareholders include FMR LLC (3,182,693 shares), ORBIMED ADVISORS LLC (1,485,000 shares), Carmignac Gestion (1,330,516 shares), Capital World Investors (736,800 shares), VANGUARD GROUP INC (728,242 shares), FRANKLIN RESOURCES INC (328,757 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (316,512 shares), BlackRock Institutional Trust Company, N.A. (307,894 shares), MILLENNIUM MANAGEMENT LLC (302,012 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (262,586 shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.